Generex Biotechnology Corp. GNBTQ
Last Post: 11/02/2024 10:15:28 AM
Board Marks: 123
Posts Today: 0
Board Views Today: 961
Post
Subject
Author
Posted On
Recent Articles
- Rediscovering The Legacy of Chinese Railroad Workers
- Celebrating Diversity: The ADCOLOR Awards of 2024 Shine Bright
- Pan-Mass Challenge Achieves Historic Fundraising Milestone
- Chancay Port Launch Boosts Economic Ties in Asia-Pacific
- Asia-Pacific Development Summit: Embracing New Opportunities
- Chancay Port: A Landmark for Asia-Pacific Economic Cooperation
- Asia-Pacific Development: A New Era of Cooperation and Growth
- Innovative Heart Research Unveiled at American Heart Association
- Johnson//Becker Takes Action Against SharkNinja for Blender Injury
- Advancements in Autoimmune Treatments: AbelZeta's C-CAR168 Study
- WATCHMAN FLX™ Device Shows Effective Stroke Prevention Methods
- Universal Music Latino Celebrates Landmark Achievements
- Breakthrough Study Identifies Key Blood Markers for RA Risk
- Gleim Exam Prep's Generous Meal Donation for Families in Need
- Biddle Real Estate Ventures Launches New Retail Hub at Potomac Shores
- Class Action Lawsuit Impacts Hasbro Stock Investors Significantly
- Chancay Port's Grand Opening: A New Era for Trade
- Herman Law's Recent Victory in Child Abuse Case Against Diocese
- Innovative Solutions Unveiled by BMC at MEDICA 2024 Event
- DENTSPLY SIRONA Inc. Under Investigation: What Investors Should Know
- TetraMem Inc Partners with SK hynix to Enhance AI Memory Tech
- BioMarin Shares Positive Real-World Evidence of VOXZOGO's Impact
- Harnessing Digital Insights to Transform Rheumatic Disease Management
- Intellia's Nexiguran Ziclumeran Shows Promise in ATTR Amyloidosis
- ASML Investors Seek Leadership Role in Class Action Lawsuit
- Eli Lilly's Tirzepatide: A Breakthrough for Heart Failure Relief
- Understanding the Class Action Against Edwards Lifesciences
- Wolfspeed, Inc. Under Scrutiny as Losses Affect Investors
- Cytokinetics Shares Promising Insights on Heart Failure Treatment
- Cytokinetics Unveils Positive Findings on Aficamten for HCM
- Seize the Chance to Own a Piece of Greenwich Village Legacy
- Revolutionary Spray Paint Remover Launched by Life After Hate
- WIN SOURCE Elevates Supply Chain Management at Major Event
- Bumble Inc. Investors: Join The Class Action Lawsuit Now
- Investors Urged to Consider Participation in Class Action for MTCH
- Investors Move to Class Action Against Caitlyn Jenner's $JENNER
- Unmissable Black Friday Deals on At-Home Laser Hair Removal
- DermRays Announces Major Discounts for Black Friday Sale
- Xi Jinping's APEC Summit Speech Inspires Business Confidence
- China's Leadership in Asia-Pacific: A New Era of Cooperation
- Al Faisal Al Baladi Holding: A New Era for Qatari Business
- Margex Partners with TradingView to Enhance Trading Experience
- Chancay Port: A New Era for Trade in Latin America
- BYD Enhances Collaboration in Energy Storage Solutions Market
- Junshi Biosciences' Toripalimab Gains UK Approval for Cancer Treatment
- Strengthening Bilateral Ties: China's Visit to Peru
- d'Alba: The K-Beauty Brand Poised for Global Recognition
- The Role of China in Driving APEC Cooperation and Growth
- Herman Law Secures Major Win in Clergy Abuse Litigation
- International Chinese Language Conference Inspires Global Education